Wanted: Long-Term "Strong Buy" Recommendations Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Wanted: Long-Term "Strong Buy" Recommendations

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Philip H. Lee who wrote ()	11/16/1996 1:17:00 AM
From: Philip H. Lee	of 54

Chiron (CHIR; 22 1/4, -5/8) $4 billion biotech leader. Has a history of innovation...one of the early leaders in combinatorial chemistry. Chiron's diagnostics division gaining revenues. Has tons of products in the pipeline. Swiss pharmaceutical giant Ciba-Geigy bought 49.6% when the stock was around 95, or a split-adjusted 24. I'm not a scientific biotech expert, but I believe in buying the leaders. Ciba's close relationship with Chiron indicates that Chiron is definitely doing something right. CHIR is also undervalued here at only 22, having sold off over the last several months. Philip

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next